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Abstract 
The aim of study is to measure serum IL-1 β, IL-6, IL-8, IFN-γ and TNF-α levels, and some of salivary 
parameters like sIgA, total protein and peroxidase specific activity in patients with chronic periodontitis in 
Mosul and compared them with control group. The study population consisted of 91 patients suffering from 
chronic periodontitis, aging between ≤18-73 years old and 18 control samples collected from healthy individuals 
ranged between 23-35 years old. Blood and saliva samples were collected from patients and control groups to 
measure serum IL-1β, IL-6, IL-8, IFN-γ and TNF-α ,and salivary sIgA , total protein levels and peroxidase 
specific activity . In the present study most of patients were showed localized chronic periodontitis, ranging 
from severe 57% to moderate infection 43%.Salivary sIgA level showed significant increase in chronic 
periodontitis comparing with control group.Patients group showed significance correlation between serum TNF-
α with serum IL-1β, IL-6 and IFN-ɣ levels. Also serum IL-1β level showed significant correlation with salivary 
sIgA and total protein levels. Furthermore negative correlations were detected between salivary sIgA and serum 
IL-8, as well asbetween salivary total protein and peroxides specific activity. 
 
 
 ------------------------------------------------------------------------ 
* Corresponding author.  
E-mail address: zeyadalrassam@yahoo.com. 
 
According to periodontal pocket depth, serum IL-1β, IFN-ɣ, salivary sIgA levels and salivary peroxidase 
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specific activity showed significance increase in patients with 7mm pocket depth. In the present study, most of 
patients showed localized chronic periodontitis. Salivary sIgA level showed significant increase in chronic 
periodontitis comparing with control group. Serum IL-1β, IFN-ɣ, salivary sIgA levels and salivary peroxidase 
specific activitywere linked with 7mm periodontal pocket depth. 
Keywords:  Periodontitis, pocket depth, cytokines, and sIgA. 
1. Introduction 
Chronic periodontitisis an infectious disease caused by specific pathogens that resist the host defenses, and 
chemotherapy. These pathogens are pioneer organisms that colonize the region of cervical gingiva and alter the 
periodontal environment to facilitate colonization of secondary organisms, which are usually more virulence 
than pioneer one [1]. The initial host immune system response to infections depends on local inflammatory 
reaction which activates innate immune system [2]. At the cellular level, the recognition and reaction with 
infectious agents include macrophages, dendritic cells and natural killer cells, neutrophils, osteoclasts and 
furthermore humeral response via T-Cells and B-cells [3,4]. 
Traditionally bacterial infection has an essential role in periodontal infection [5], but periodontum tissues 
destruction as a result of host immune system response to presence of pathogens via pro-inflammatory cytokines 
production within periodontal tissue and periodontal sulcus fluid, including interleukin-1beta (IL-1β), 
interleukin-6 (IL-6), matrix metallo proteases (MMPs), prostaglandin E2 (PGE2),tumor necrosis factor-alpha 
(TNF-α), and immunoglobulins [6,7]. The elevation of inflammatory mediators with failure to encapsulate this 
inflammatory  within gingival tissue leads to expansion of the response adjacent to underlying tissues and 
destroy the supporting periodontal tissues [8]. 
2. Materials and  Methods 
        2.1. Subject Groups 
The subjects in this study were 91 patients with chronic periodontitisaging between ≥18 - 73 years old, (57 
males aged 18 to 73 years, mean age, 37.33 years, and 34 females aged 18 to 63 years, mean age, 32.14 years. 
Patients referred to Periodontal Clinic in the College of Dentistry/Mosul University from January 2011 to April 
2012.  
2.2. Control Group  
This group consisted of 18 clinically healthy ranged between 23-35 years old. (18 males aged 23 to 35 years and 
3 females aged 23 to 30 years) working in Mosul University. This group had no signs of any systemic disease, 
gingivitis or any type of periodontitis.All patients and the healthy individuals underwent anoral examination and 
selected by a specialist.Patients withchronic periodontitis status have ˃3-≥7mm pockets depth,according to the 
classification of the periodontal diseases issued by the American Academy of Periodontology in 1999 [9].  
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2.3. Data Source 
Case sheet was performed especially for the purpose of examination. 
2.4. Sample collecting 
Periodontitis patients had no clinical evidence of previous periodontal destruction with more than 3 mm probing 
depth at 3 or more sites, while the healthy controls had no clinical evidence of periodontal disease, healthy 
gingival sites showed neither periodontal attachment loss nor gingival inflammation and exhibited periodontal 
probing depth equal to or less than 3 mm.  
2.4.1. Serum collecting 
5ml of blood was collected from patients and control groups, serum was dispensed by centrifugation at 2500 rpm 
for10 min and aliquotedin a sterile plastic Eppendorff tubes (0.5ml) and stored at -20˚C until the time of analysis 
[10]. 
2.4.2. Collection of Saliva 
Unstimulated saliva was collected from patients and control groupsvia passive drooling into a sterilized 
disposable collectorcup.Saliva was centrifuged at 3000 rpmfor 10 min. The clear supernatant fraction was then 
separated and dispensed in Eppendorff tubes and stored at -20˚C until required for analysis [11]. 
      2.5. Materials and KitsUsed in Serological Tests 
1. Human Interleukin-1β ELISA kit, ABO SwitzerlandCo., Ltd. (China). 
2. Human Interleukin-6 ELISA kit, ABO Switzerland Co., Ltd. (China). 
3. Human Interleukin-8 ELISA kit, Immune Leader, (China). 
4. Human interferon-γ ELISA kit, ABO Switzerland Co., Ltd. (China). 
5. Human Tumor Necrosis Factor-α ELISA kit, ABO Switzerland Co., Ltd. (China). 
          2.6. Materials and kit Used for Salivary Serological and Biochemical Study 
1. Salivary sIgA ELISA kit, Dia Metra, ( Italy). 
2. Saliva total protein biochemical test kit, BIOLABO S.A,( France).  
3. Saliva peroxidase test.  
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2.7. Statistical Analysis 
T-Test, Pearson Chi-Square Test, Pos Hoc Test, ANOVA Test, Duncan Test, Correlations, Mean, Std. 
Deviation, Std. Error. 
 
3. Results 
In the present study most of patients showed localized chronic periodontitis, 57% of them suffered from severe 
infection (≥5 mm pocket depth), and 43% of them have moderate infection (≥3-4 mm pocket depth). (Figure 1) 
 
 
Figure (1): Infection status according to pocket depth 
 
         3.1. Comparison between chronic periodontitis and control groups 
The comparison between chronic periodontitis  and control groups using serum IL-1 β,  IL-6, IL-8, IFN-γ and 
TNF-α levels and some of salivary parameters like sIgA , total protein and peroxidase specific activity showed 
increase in the above parameter levels, but statistically not significant, except salivary sIgA levels which was 
statistically significant (Table 1) . 
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Table (1): Comparison of some cytokines and salivary parameters between chronic periodontitis  and control 
groups 
Significance 
p. 
value 
Patients  n(91) 
Mean ± Std. 
Deviation 
Control   n(18) 
Mean ± Std. 
Deviation 
 
Non 0.514 59.195 ± 26.560  25.0553 ± 6.109 
IL- 8 
pg/ml 
Non 0.260 21.810 ± 18.041 13.366 ± 1.851 
IL- 6 
ng/ml 
Non 0.629 76.0736± 41.864 26.666 ± 4.8442 
IL- 1β 
pg/ml 
Non 0.607 453.948± 397.130 300.666 ± 16.415 
IFN-ɣ 
ng/L 
Non 0.651 333.1263 ±279.301 280.833 ± 20.143 
TNF-α 
ng/L 
Significance 0.019 69.266 ± 27.0799 42.549 ± 14.0799 
Salivary sIgA 
µg/ml 
Non 0.383 3.2937 ± 1.6351 2.701 ± 0.860 
Salivary total protein 
mg/ml 
Non 0,098 0.05411± 0.05243 0.01530 ± 0.0091 
Salivary peroxides 
specific activity  
u/mg 
 
 
3.2. Correlation between some of cytokines and parameters within periodontitis patients group 
The present study showed significant association among cytokines and salivary parameters within patients group 
as summarized below:  
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First, presence of significance correlation between serum TNF-α with serum IL-1β, IL-6 and IFN-ɣ levels. 
Second, serum IL-1β level showed significant correlation with salivary sIgA and total protein levels. Finally 
negative correlation detected between salivary total protein and peroxides specific activity, and between salivary 
sIgA with IL-8(Tables 2). 
 
Table (2): Correlation between some of cytokines and parameters within periodontitis group. 
Saliva 
peroxides 
Specific 
activity 
Saliva 
total 
protein 
Saliva 
sIgA 
TNF-α IFN-ɣ IL- 1β IL- 6 IL-8 
  
0.069 0.076 -0.359** 0.768** 0.122 0.052 0.206 1 
Pe
ar
so
n 
C
or
re
la
tio
n 
IL- 8 
-0.033 0.0202 0.117 0.457** 0.312* 0.331* 1  IL- 6 
-0.089 0.478** 0.276* 0.398** 0.711** 1   IL- 1β 
-0.134 0.491** 0.260 0.474** 1    IFN-ɣ 
-0.016 0.256 -0.102 1     TNF-α 
0.141 0.264* 1      Saliva sIgA 
-0.412** 1       
Saliva total 
protein 
1        
Salivary 
peroxides 
Specific 
activity 
**. Correlation is significant at the 0.01 level . *. Correlation is significant at the 0.05 level.n.= 91 
 
3.3. Relationships between parameter concentrations and periodontal pocket depth in periodontitis 
patients group  
The comparison between some parameter levels and their relation with periodontal pocket depth within 
periodontits group, showed no statistical significance differences between serum IL-6, IL-8, TNF-α levels and 
salivary total proteins concentration. (Figures 2). However IL-1β and IFN-ɣ levels showed statistically 
significant increase in patients with periodontal pocket depth 7mm, whereas salivary sIgA showed significant 
increase in patients with both 7mm and 3mm pocket depth (Figure 3). The relationship between salivary 
peroxidase specific activity and periodontal pocket depth showed significant increase in patients with 7mm 
pocket depth. However there was no significance variation in its activity with other depths (Figure 3). 
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Figure (2): Relationships between serum parameters concentrations and periodontal pocket depth in 
periodontitis patients 
 
 
 
Figure (3): Relationships between salivary parameters concentrations and periodontal pocket depth in 
periodontitis patients group 
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5.   Discussion and conclusions  
In this study most of patients showed localized chronic periodontitis, 57% of them suffered from severe 
infection and 43% of them have moderate infection. In chronic periodontitis the periodontal epithelium surface 
exposed to invasion pathogens ranged between 8-20 cm2, therefore  chronic and aggressive periodontitis are 
similar to systemic infection [12]. 
The Comparison between chronic periodontitis and control groupsshowed nosignificant differences inserum IL-
1 β, IL-6, IL-8, IFN-γ, TNF-α levels, total protein concentration and peroxidase specific activity.Periodontitis 
inflammatory reaction is initiated as a response to the presence of pathogens and their products which stimulatea 
cellular immune system to release cytokines and other mediators leading to extinction of the inflammation 
throughout the gingival tissues reaching the connective tissue and alveolar bone [13]. Thus the inflammatory 
bone resorption depends upon the concentration of inflammatory mediators that reaching the alveolar bone [2]. 
IL-1β is a pro-inflammatory cytokine which regulates IL-6 production and stimulates bone resorption [14,15]. 
These foundations support the observations of the current study .IL-6 plays a regulatory key role in chronic 
periodontitis via modulating periodontum local host responses [16]. Raunio and his colleagues observed a 
significant increased in serum IL-6 level in chronic periodontitis patients comparing with control groups [17], 
but in the present study there was no significant differences, such differences may depend on several  factors : 
First, the severity of  periodontits in the present study, most of patients  showed localized chronic periodontitis, 
57% of them suffered from severe infection (≥5 mm pocket depth), and 43% of them have moderate infection 
(≥3-4 mm pocket depth). Second, the subjects in the control group may have subclinical diseases which 
confused the result. Generally IL-6 levelcould be used as biomarker to determine gingivitis and periodontitis 
susceptibility and periodontal therapy prognosis [18]. 
IL-8 is a chemokine increases as a result of any inflammatory conditions which chemoattract and increase 
neutrophils phagocytic activity against invading agents [19, 20]. The current result showed agreement with 
Ladez and his colleagues who observed no significant difference in serum IL8 level between periodontitis and 
healthy groups [21]. 
Andrukhov and his colleagues observed the presence of positive association between serum TNF-α level and 
periodontal inflammation [22]. TNF-α is an early cytokine which induces production of IL-1β, IL-6and 
enhances migration of inflammatory cells to the site of inflammation [23]. Also TNF-α stimulates production of 
matrix metallo proteinases, which enhances bone loss [24, 25]. Thus non significance variations in the present 
result may be associated with infection status. TNF-α is a pro-inflammatory cytokine which is increased in the 
early infection status and deceased with time as a result of IL-6 activity which acts as an anti-inflammatory 
cytokine [26]. 
IFN-γ has immune modulator properties,which is produced as a part of the innate immune response against 
infections [27]. Kobayashi and his colleagues didn’t observe a significance association between serum TNF-α 
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level and periodontal infection, but it is linked with IL-12 level [28]. This concept may support the current 
results. 
Salivary sIgA level shows significance increase in its level within periodontitis patients comparing with control 
groups. Similar observation has been achieved by others [29]. Salivary sIgA is considered as one of the main 
immune defense mechanism in saliva via binding to soluble and particulate antigens [30] as well as it inhibits 
various enzymes and bacterial colonization on oral hard surfaces [30]. Therefore Olayanju and his colleagues 
suggested the use of salivary sIgA level elevation as a screening tool for periodontitis [31]. 
Salivary peroxidase specific activity showed increase in peridontitis patients than control group. Peroxidase 
enzyme protects oral cavity via inhibiting bacterial growth and preventing hydrogen peroxide and dental biofilm 
acid accumulation [32]. Although its increase is not significance but this result is similar to Guven and his 
colleagues observation who noted thatsalivary peroxidase remained constant within a normal range in several 
diseases [33], but its elevation in periodontits patients may be an indication of periodontal disorder [34]. 
In this study thecorrelation between some of cytokines and other parameters in periodontitis patients 
wereshoweda significance correlations between serum TNF-α with serum IL-1β, IL-6 and IFN-ɣ levels. Several 
studies demonstrated that IL-1 β, IL-6, IFN-γ and TNF-α, induce several reactions associated with 
inflammation, tissue destruction and bone resorption [18,35,36]. Periodontitis like other inflammatory disease 
can also affect on cytokines concentrations, thus periodontal infections depend on fluctuation of mediators 
levels, expression of pro inflammatory cytokines, which play a critical role in the destruction of connective 
tissues and alveolar bone that support the teeth [37]. But expression of anti-inflammatory cytokines and other 
mediators serve as bone resorption inhibiter, such as IFN-β and IFN- γ [38]. In the present study the comparison 
between some parameter levels and their relation with periodontal pocket depthshowed no statistical 
significance between serum IL-6, IL-8, TNF-α levels and salivary total proteins concentration, within 
periodontits group. IL-1β, IFN-ɣ, salivary sIgA, levels and salivary peroxidase specific activity showed 
statistically significant increase in patients with periodontal pocket depth 7mm. However there were no 
significance variations in its activity with other depths. Górska and his colleagues observed clear relationship 
between clinical parameters and  IL-1β, TNF-α and IFN-γ concentrations within inflamed gingival tissues and 
serum samples of severe chronic periodontitis patients and suggested that they have an important role in the 
initiation and progression of periodontal disease [39]. 
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